We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.31B
AUM Growth
-$8.31M
Cap. Flow
-$167M
Cap. Flow %
-12.7%
Top 10 Hldgs %
42.17%
Holding
161
New
18
Increased
32
Reduced
41
Closed
18

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$11.9M
2
PDD icon
Pinduoduo
PDD
+$10.9M
3
BBIO icon
BridgeBio Pharma
BBIO
+$9.19M
4
ITOS
iTeos Therapeutics
ITOS
+$6.95M
5
NE icon
Noble Corp
NE
+$6.73M

Top Sells

Rank Stock Value
1
SN icon
SharkNinja
SN
+$36.5M
2
BWA icon
BorgWarner
BWA
+$13.2M
3
SE icon
Sea Limited
SE
+$12.1M
4
BABA icon
Alibaba
BABA
+$9.88M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$7.45M

Sector Composition

Rank Sector Weight
1 Healthcare 23.33%
2 Consumer Discretionary 14.69%
3 Financials 6.56%
4 Materials 4.95%
5 Communication Services 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMLX icon
51
Amylyx Pharmaceuticals
AMLX
$2.42B
$6.48M 0.49%
2,000,000
+498,129
+33% +$1.12M
WDFC icon
52
PUT
WD-40
WDFC
$3.17B
$6.45M 0.49%
25,000
-25,000
-50% -$6.27M
AGRO icon
53
Adecoagro
AGRO
$1.34B
$6.25M 0.48%
565,000
+65,000
+13% +$680K
NE icon
54
Noble Corp
NE
$6.38B
$6.04M 0.46%
+167,118
New +$6.73M
APLS
55
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$5.77M 0.44%
200,000
– –
GOSS icon
56
Gossamer Bio
GOSS
$87.2M
$5.72M 0.44%
5,800,000
+50,000
+0.9% +$48.1K
CCTS
57
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
$5.18M 0.39%
450,000
– –
PCSC
58
DELISTED
Perceptive Capital Solutions
PCSC
$5.01M 0.38%
500,000
– –
BABA icon
59
Alibaba
BABA
$308B
$4.72M 0.36%
44,500
-120,700
-73% -$9.88M
IRS.WS
60
DELISTED
IRSA Inversiones y Representaciones S.A. Warrants
IRS.WS
$4.61M 0.35%
4,750,000
+78,530
+2% +$71.1K
COIN icon
61
PUT
Coinbase
COIN
$39.8B
$4.45M 0.34%
25,000
-25,000
-50% -$5.01M
SAGE
62
DELISTED
Sage Therapeutics
SAGE
$4.33M 0.33%
600,000
+100,000
+20% +$916K
ABEO icon
63
Abeona Therapeutics
ABEO
$385M
$4.27M 0.32%
675,000
+75,000
+13% +$392K
RXO icon
64
RXO
RXO
$3.52B
$4.19M 0.32%
149,800
-140,200
-48% -$3.96M
ASML icon
65
ASML
ASML
$651B
$4.17M 0.32%
+5,000
New +$4.47M
VIGL
66
DELISTED
Vigil Neuroscience
VIGL
$4.15M 0.32%
1,219,580
+119,580
+11% +$443K
BMRN icon
67
BioMarin Pharmaceuticals
BMRN
$11.6B
$3.73M 0.28%
+53,000
New +$4.43M
BTI icon
68
British American Tobacco
BTI
$128B
$3.66M 0.28%
100,000
– –
CYPH
69
Cypherpunk Technologies Inc
CYPH
$75.4M
$3.55M 0.27%
1,380,500
+80,500
+6% +$197K
HCC icon
70
Warrior Met Coal
HCC
$4.39B
$3.51M 0.27%
+55,000
New +$3.42M
SOLV icon
71
Solventum
SOLV
$14.9B
$3.49M 0.27%
50,000
-75,000
-60% -$4.51M
MODD icon
72
Modular Medical
MODD
$11.2M
$3.42M 0.26%
50,667
-166
-0.3% -$8.95K
IFRX icon
73
InflaRx
IFRX
$259M
$3.17M 0.24%
2,070,000
– –
IVVD icon
74
Invivyd
IVVD
$177M
$3.06M 0.23%
3,000,000
-625,000
-17% -$677K
ROIV icon
75
Roivant Sciences
ROIV
$25.1B
$3.01M 0.23%
261,000
-149,000
-36% -$1.7M
1 2
3
4 5

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, 683 Capital Management held 161 positions worth $1.31B, down 0.63% from $1.32B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

683 Capital Management withdrew a net $167M in Q3 2024, closing 18 positions and reducing 41 holdings. Its most notable exit was Sea Limited, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in Pinduoduo worth $12M.

  • 683 Capital Management's largest Q3 2024 buy was Pinduoduo: 89,000 shares worth $12M.
  • 683 Capital Management added most to Baidu in Q3 2024, an estimated $11.9M increase.
  • 683 Capital Management's biggest Q3 2024 reduction was SharkNinja, cutting an estimated $36.5M.
  • 683 Capital Management fully exited Sea Limited in Q3 2024, selling an estimated $12.1M.
  • 683 Capital Management's ten largest holdings make up 42% of its $1.31B portfolio in Q3 2024.
  • 683 Capital Management opened 18 new positions and closed 18 in Q3 2024.
  • 683 Capital Management's portfolio value fell 0.63% quarter-over-quarter to $1.31B.

Based on 683 Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.